Article Text

other Versions

Antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis
  1. M Vargović1,
  2. M Pasini2,
  3. N Papić1,
  4. S Andrašević1,
  5. A Markotić1,3,
  6. I Butić1,
  7. V Škerk1,4
  1. 1University Hospital for Infectious Diseases ‘Dr. Fran Mihaljević’, Zagreb, Croatia
  2. 2University Hospital Centre Zagreb, Zagreb, Croatia
  3. 3University School of Medicine Rijeka, Rijeka, Croatia
  4. 4School of Dental Medicine, University of Zagreb, Zagreb, Croatia
  1. Correspondence to Professor Višnja Škerk, Clinical Department for Urinary Tract Infections, University Hospital for Infectious Diseases ‘Dr. Fran Mihaljević’, Zagreb, Croatia; vskerk{at}

Statistics from

Ureaplasma urealyticum and Mycoplasma hominis are common commensals of the lower genitourinary tract. They are causally linked to prostatitis, epydidimitis, urethral syndrome, cervicitis, urolythiasis, reactive arthritis, infertility, complications during pregnancy and serious infections in newborns and immunocompromised hosts.1 Therefore, the therapeutic use of antimicrobials and susceptibility testing is necessary because it allows adequate treatment.

The aim of this study was to determine the susceptibility of U urealyticum and M hominis to tetracycline, erythromycin, clindamycin, doxycycline, ofloxacin and azithromycin.

This study was conducted at the …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.